Blood cancer Clinical Trials in Omaha, NE

As of June 2026, 44 paid clinical trials are recruiting for Blood cancer in Omaha, Nebraska. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

44 clinical trials for Blood cancer

·Clear filters·↓ Download CSV

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for Lymphoma, Non-Hodgkin

174 locations incl. Birmingham

Sponsor: American Society of Clinical Oncology

Sex: All·Age: 12+

Code: NCT02693535·Phase 2·Recruiting

Apply to this trial

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

245 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting

Apply to this trial

Integrated Cancer Repository for Cancer Research

for Pancreatic Cancer

42 locations incl. Greenwood Village

Sponsor: University of Nebraska

Sex: All·Age: 19 - 110·Accepts healthy volunteers

Code: NCT02012699·Recruiting

Apply to this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for Hematologic Malignancies

142 locations incl. Birmingham

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: All ages

Code: NCT01351545·Recruiting

Apply to this trial

Conditions in Blood cancer (Omaha, NE)

Multiple myeloma· 14 Non-Hodgkin lymphoma· 11 Acute myeloid leukemia (AML)· 8 Diffuse large B-cell lymphoma (DLBCL)· 8 Leukemia (other)· 7 Hematologic malignancy· 7 Chronic lymphocytic leukemia (CLL)· 6 Myelodysplastic syndromes (MDS)· 3 Myeloproliferative neoplasm· 3 Mantle cell lymphoma· 3 Acute lymphoblastic leukemia· 2 Follicular lymphoma· 2 Marginal zone lymphoma· 2 Myelofibrosis· 1 Hodgkin lymphoma· 1 Small lymphocytic lymphoma· 1